Nebivolol and the Endothelin (ET)-1 System
Public ClinicalTrials.gov record NCT01395329. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01395329
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- University of Colorado, Boulder
- Other
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- Nebivolol Drug
- Metoprolol Drug
- Placebo Drug
- Forearm Blood Flow (FBF) response to BQ-123 (100 mol/min) Other
- FBF response to BQ-123 (100 nmol/min)+BQ-788(50 nmol/min) Other
- FBF response to Acetylcholine Other
- FBF response to Sodium Nitroprusside Other
- FBF response to BQ-123+BQ-788+ACh Other
Drug · Other
Eligibility (public fields only)
- Age range
- 45 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2011
- Primary completion
- Oct 31, 2016
- Completion
- Nov 30, 2016
- Last update posted
- Jan 1, 2019
2011 – 2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC-Boulder Clinical and Translational Research Center | Boulder | Colorado | 80309 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01395329, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 1, 2019 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01395329 live on ClinicalTrials.gov.